Eledon Pharmaceuticals, Inc. Balance Sheet
ELDN|3 years of annual SEC 10-K data (FY2014-FY2016)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
Eledon Pharmaceuticals, Inc. had $30M in total assets and $62M in shareholders' equity as of FY2016.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2016 | FY2015 | FY2014 |
|---|---|---|---|
| Cash & Equivalents | $24.0M | $31.8M | $11.7M |
| Current Assets | $29.5M | $67.2M | $107.5M |
| PP&E (Net) | $98.0K | $489.0K | $33.0K |
| Total Assets | $29.8M | $68.0M | $107.7M |
| Current Liabilities | $2.8M | $6.2M | $4.2M |
| Shareholders' Equity | $61.7M | -$55.3M | -$39.9M |